The Spanish Biotech sector will have a place in the radio The European Commission grants a project to Bionanoplus to develop a veterinary vaccine as part of the “SME Instrument” program

Bionanoplus will participate in a major European Project that will explore an innovative and sustainable in situ self-assembly nanoencapsulation technology to deliver novel products for skin healthcare applications

Bionanolus will participate in the European research project SKHINCAPS (SKin Healthcare by Innovative NanoCAPsuleS), financed by the European Union Horizon 2020 Programme (H2020). The consortium is comprised of several prestigious research centers and companies from different stages of the supply chain, so it will promote stronger collaborations between materials suppliers, manufacturers and end-users.

SKHINCAPS project intends to provide a safe, sustainable, easy scalable and cost-effective solution for the development of personal skin care products (textiles and cosmetics) containing stimuli-responsive nanocapsules. The project goals will contribute to overcome the challenges Europe is facing on the global competition and efficient use of energy and resources, due to the wide applicability and high growth markets that will be addressed and to the sustainability of the technology involved.

The European consortium will be led by the Centre for Nanotechnology and Smart Materials (CeNTI) which is based in Portugal. Its role is to drive the development of new materials in order to contribute to product or innovation through all the necessary stages of development.

The other members of the consortium include the Institut für Verbundwerkstoffe GmbH from Germany, the Polytechnic University of Catalonia from Spain, Devan Chemicals from Belgium, Telic Group from Spain, VTT Technical Research Centre of Finland, Pro-Active sprl from Belgium, and the Instituto Tecnológico de Óptica, Color e Imagen (AIDO) from Spain.

Within the context of this project, Bionanoplus will be responsible for nanoencapsulating the different actives using its proprietary technology.

The SKHINCAPS project will constitute a great opportunity for Bionanoplus to work with top international technology partners contributing to a quality of life issue of great significance at both European and international level.

  • Share